These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 9206021)
1. Gene therapy: regulatory issues and international approaches to regulation. Cohen-Haguenauer O Curr Opin Biotechnol; 1997 Jun; 8(3):361-9. PubMed ID: 9206021 [No Abstract] [Full Text] [Related]
2. Overview of regulation of gene therapy in Europe: a current statement including reference to US regulation. Cohen-Haguenauer O Hum Gene Ther; 1995 Jun; 6(6):773-85. PubMed ID: 7548277 [No Abstract] [Full Text] [Related]
3. Recombinant DNA Advisory Committee: minutes of meeting, 3 Oct 1988. U.S. National Institutes of Health. Recombinant DNA Advisory Committee Recomb DNA Tech Bull; 1988 Dec; 11(4):155-94. PubMed ID: 11644344 [No Abstract] [Full Text] [Related]
4. Hidden costs of a clean inheritance. Coghlan A New Sci; 1994 May; 142(1925):14-5. PubMed ID: 11656348 [No Abstract] [Full Text] [Related]
5. National and international approaches to human germ-line gene therapy. Bonnicksen AL Politics Life Sci; 1994 Feb; 13(1):39-49. PubMed ID: 11654819 [No Abstract] [Full Text] [Related]
6. Gene trial causes ethical storm in New Zealand. Coney S Lancet; 1996 Jun; 347(9017):1759. PubMed ID: 11654364 [No Abstract] [Full Text] [Related]
7. Japan on verge of first gene therapy trial. Hannay T Nat Med; 1995 Jan; 1(1):9. PubMed ID: 11644732 [No Abstract] [Full Text] [Related]
8. The social warp of science: writing the history of genetic engineering policy. Wright S Sci Technol Human Values; 1993; 18(1):79-101. PubMed ID: 11652076 [No Abstract] [Full Text] [Related]
10. Trends in gene therapy regulation. Lecomte V; Taylor A Gene Ther; 1997 Feb; 4(2):77-8. PubMed ID: 11644906 [No Abstract] [Full Text] [Related]
11. Legal regulation of human gene therapy. Areen J; King P Hum Gene Ther; 1990; 1(2):151-61. PubMed ID: 2078576 [TBL] [Abstract][Full Text] [Related]
12. Public oversight is necessary if human gene therapy is to progress. Zallen DT Hum Gene Ther; 1996 May; 7(7):795-7. PubMed ID: 8860831 [No Abstract] [Full Text] [Related]
13. European debate on biotech highlights policy differences. Abbott A Nature; 1996 Jan; 379(6562):197. PubMed ID: 8538779 [No Abstract] [Full Text] [Related]
14. Gene-splice oversight. Parens E Washington Post; 1996 Jun; ():A21. PubMed ID: 11646331 [No Abstract] [Full Text] [Related]
15. International and European regulation of recombinant DNA research. Tooze J Univ Toledo Law Rev; 1981; 12(4):869-90. PubMed ID: 11649589 [No Abstract] [Full Text] [Related]
16. Research ethics review in Australia, Europe and North America. McNeill PM IRB; 1989; 11(3):4-7. PubMed ID: 11650207 [No Abstract] [Full Text] [Related]
17. The quality of mercy. Crigger BJ Hastings Cent Rep; 1993; 23(3):3. PubMed ID: 11643129 [No Abstract] [Full Text] [Related]
18. A triumph of hope. New Sci; 1997 May; 154(2084):3. PubMed ID: 11656657 [No Abstract] [Full Text] [Related]
19. A legal perspective on the control of the technology of genetic engineering. Cripps YM Mod Law Rev; 1981 Jul; 44(4):369-87. PubMed ID: 11650549 [No Abstract] [Full Text] [Related]
20. The development of regulatory standards for gene therapy in the European Union. De Jager CF Fordham Int Law J; 1995 Apr; 18(4):1303-39. PubMed ID: 11657449 [No Abstract] [Full Text] [Related] [Next] [New Search]